Pharma Stocks
-
Lupin, Aurobindo, Sun Pharma fall up to 4%: Why are pharma stocks falling today?
Dalal Street witnessed a broad-based selloff in early trade on Wednesday, with the Sensex tanking more than 500 points and…
Read More » -
China Pharma Holdings, Inc. Comments on Unusual Market Activity
HAIKOU, China, July 21, 2026 /PRNewswire/ — China Pharma Holdings, Inc. (NYSE American: CPHI) (“China Pharma” or the “Company”), a fully-integrated…
Read More » -
HEPA stock trades steadily as Hepion Pharma highlights chronic liver disease pipeline and recent fun
Hepion Pharma Inc. (ISIN US4268971032), whose shares trade under the HEPA ticker on Nasdaq, positions HEPA stock as a specialist…
Read More » -
Innate Pharma Completes Dose Escalation of IPH4502, Results Expected by End of 2026
The biopharmaceutical laboratory announced the completion of recruitment in the dose escalation part of its Phase 1 study evaluating IPH4502,…
Read More » -
Nifty, Sensex open cautiously; banking, pharma stocks weigh
The Sensex, which had closed Monday’s session at 77,708.52, opened at 77,649.63 and was trading at 77,720.47, up 11.95 points…
Read More » -
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500…
Read More » -
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
The iShares Global Healthcare ETF (IXJ 0.48%) provides broad global sector exposure, while VanEck Pharmaceutical ETF (PPH 1.00%) offers a…
Read More » -
Ionis Pharmaceuticals Stock Slides 37% Over 8 Straight Down Days
A persistent slide in the biotech’s stock price prompts a closer look at the numbers behind the momentum. Ionis Pharmaceuticals…
Read More » -
Natco Pharma shares surge 5% after US FDA’s tentative nod Olaparib tablets
Natco Pharma shares climbed as much as 4.5% on Monday, touching an intraday high of Rs 987.55 on the NSE,…
Read More » -
Did Jazz’s Sleep and Oncology Pipeline Momentum Just Shift Jazz Pharmaceuticals’ (JAZZ) Investment Narrative?
In recent months, Jazz Pharmaceuticals has drawn fresh attention as investors reassess its sleep-disorder and oncology portfolios amid growing interest…
Read More »